Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Role of Immunosuppressive Therapy on Clinical, Immunological, and Angiographic Outcome in Active Takayasu's Arteritis

ANAND K. VALSAKUMAR, UMESAN CHIRAMMAL VALAPPIL, VINOD JORAPUR, NAVEEN GARG, SONIYA NITYANAND, and NAKUL SINHA

ABSTRACT.

Objective.
To evaluate the role of an immunosuppressive regimen consisting of azathioprine and prednisolone on the clinical, immunological, and angiographic outcome in patients with active Takayasu's arteritis (TA).

Methods. Between January 1996 and January 2001, of 65 consecutive newly diagnosed patients with TA not previously treated by any immunosuppressive therapy, 15 fulfilled the criteria for disease activity. Detailed clinical and laboratory evaluation was carried out in these patients. They were treated with a combination of azathioprine and prednisolone for one year, and aortography was carried out in all patients before and after completion of the treatment.

Results. All patients had improvement in systemic symptoms and laboratory measures of disease activity within a period of 3 months of onset of treatment. Erythrocyte sedimentation rate decreased from a mean of 55.5 ± 14.7 mm/h to 21.9 ± 9.5 mm/h within 3 months (p < 0.001) and further to 20.8 ± 15.2 at one year (p = NS). C-reactive protein concentrations fell from 4.8 ± 5.2 mg/dl to 0.5 ± 0.2 mg/dl at 3 months (p = 0.004) and remained at 0.5 ± 0.3 mg/dl at one year (p = NS). No changes in the peripheral pulses or differences in limb blood pressures were noted. Repeat angiograms revealed no significant changes compared to baseline. No new lesion appeared in any patient. The immunosuppressive therapy was well tolerated with no notable side effects.

Conclusion. An immunosuppressive regimen of azathioprine and prednisolone is safe, well tolerated, and effective in ameliorating systemic symptoms and laboratory measures of disease activity in TA, and at least halts progression in angiographic lesions at one year of followup, although it does not seem to lead to a regression of the arterial lesions. (J Rheumatol 2003;30:1793-8)

Key Indexing Terms:

TAKAYASU'S ARTERITIS
IMMUNOSUPPRESSIVE THERAPY
ANGIOGRAPHY


From the Department of Cardiology, and Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

A.K. Valsakumar, MD, DM, Senior Resident; U. Chirammal Valappil, MD, DM, Senior Resident; V. Jorapur, MD, DM, Senior Resident; N. Garg, MD, DM, DNB, FACA, Assistant Professor, Department of Cardiology; S. Nityanand, MD, PhD, Associate Professor, Department of Clinical Immunology; N. Sinha, MD, DM, FSCAI, FACC, Professor, Head, Department of Cardiology.

Address reprint requests to Prof. N. Sinha, Department of Cardiology, Sanjay Gandhi PGIMS, Lucknow UP, India 226014. E-mail: nsinha@sgpgi.ac.in

Submitted January 21, 2000; revision accepted January 10, 2003.




Return to August 2003 Table of Contents



© 2003. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.